Zafirovska Taleska, Biljana

Preferred name

Official Name

Zafirovska Taleska, Biljana

Translated Name

Зафировска Талеска, Билјана

Alternative Name

Б Зафировска

Билјана Зафировска Талеска

Б. Зафировска Талеска

Zafirovska Biljana

Zafirovska B

Зафировска Билјана

Зафировска Б

Зафировска Талеска Б

Biljana Zafirovska

B Zafirovska

B. Zafirovska

B. Zafirovska Taleska

Билјана Зафировска

Main Affiliation

bibi_zafir@yahoo.com

Researcher ID

https://orcid.org/0000-0002-7377-3384

Now showing 1 - 10 of 51

Some of the metrics are blocked by your
consent settings
Radial artery anomalies in the Macedonian population during transradial angiography procedures
(Association of Medical Doctors "Sanamed" Novi Pazar, 2016)
;
Petkoska, Danica
;
Antov, Slobodan
;
Vasilev, Ivan
;
Jovkovski, Aleksandar
Some of the metrics are blocked by your
consent settings
Finding the optimal access for proximal upper limb artery (PULA) interventions: Lessons learned from the PULA multicenter registry
(Wiley, 2021)
Nardai, Sándor
;
;
Pataki, Ákos
;
Nemes, Balázs
;
Tóth, Júlia
The multicenter proximal upper limb artery (PULA) Registry was created to study the optimal puncture sites for the interventions involving the subclavian, axillary, and innominate arteries.
Some of the metrics are blocked by your
consent settings
SYNERGY-Everolimus-Eluting Stent With a Bioabsorbable Polymer in ST-Elevation Myocardial Infarction: CLEAR SYNERGY OASIS-9 Registry
(Elsevier BV, 2024-06-01)
Jolly, Sanjit S
;
Lee, Shun Fu
;
Mian, Rajibul
;
;
Lavi, Shahar
Our objective was to evaluate the clinical effectiveness of the SYNERGY stent (Boston Scientific Corporation, Marlborough, Massachusetts) in patients with ST-elevation myocardial infarction (STEMI). The only drug-eluting stent approved for treatment of STEMI by the Food and Drug Administration is the Taxus stent (Boston Scientific) which is no longer commercially available, so further data are needed. The CLEAR (Colchicine and spironolactone in patients with myocardial infarction) SYNERGY stent registry was embedded into a larger randomized trial of patients with STEMI (n = 7,000), comparing colchicine versus placebo and spironolactone versus placebo. The primary outcome for the SYNERGY stent registry is major adverse cardiac events (MACE) as defined by cardiovascular death, recurrent MI, or unplanned ischemia-driven target vessel revascularization within 12 months. We estimated a MACE rate of 6.3% at 12 months after primary percutaneous coronary intervention for STEMI based on the Thrombectomy vs percutaneous coronary intervention alone in STEMI (TOTAL) trial. Success was defined as upper bound of confidence interval (CI) to be less than the performance goal of 9.45%. Overall, 733 patients were enrolled from 8 countries with a mean age 60 years, 19.4% diabetes mellitus, 41.3% anterior MI, and median door-to-balloon time of 72 minutes. The MACE rate was 4.8% (95% CI 3.2 to 6.3%) at 12 months which met the success criteria against performance goal of 9.45%. The rates of cardiovascular death, recurrent MI, or target vessel revascularization were 2.7%, 1.9%, 1.0%, respectively. The rates of acute definite stent thrombosis were 0.3%, subacute 0.4%, late 0.4%, and cumulative stent thrombosis of 1.1% at 12 months. In conclusion, the SYNERGY stent in STEMI performed well and was successful compared with the performance goal based on previous trials.
Some of the metrics are blocked by your
consent settings
Transradial carotid artery stenting using double layer micromesh stent and novel post-dilation balloon with integrated embolic protection
(Elsevier BV, 2024-06)
Petkoska Spirova, Danica
;
;
Vasilev, Ivan
;
Saylors, Elizabeth
;
Sachar, Ravish
The highest rate of embolization during carotid artery stenting occurs during post-dilation. We evaluated the ability of the Paladin system (Contego Medical, Raleigh, NC), a novel PTA balloon with an integrated 40-ɥm pore filter, to collect microemboli that may pass into the cerebral circulation when used during post-dilation.
Some of the metrics are blocked by your
consent settings
Benefit of routine preprocedural radial artery angiography in STEMI patients
(Wiley, 2018)
;
Slobodan Antov
;
;
;
Ivan Vasilev
To assess the benefit of routine preprocedural radial artery (RA) angiography in patients with ST segment elevation myocardial infarction (STEMI).
Some of the metrics are blocked by your
consent settings
Strategies to Promote Long-Term Cardiac Implant Site Health
(Cureus, Inc., 2021-01-03)
;
In the past several decades there has been a continuous growth in the field of cardiac implantable electronic devices (CIED) implantation procedures as well as their technological development. CIEDs utilize transvenous leads that are introduced into the heart via the axillary, subclavian, or cephalic veins, as well as a devices generator that is implanted in a subcutaneous pocket, typically in the pre-pectoral region. Despite this significant improvement, complication rates range from 1-6% with current implant tools and techniques. In this review we will discuss the three central parts of the CIED implantation procedure, their impact on implantation site, infections, and possibilities for its prevention.
Some of the metrics are blocked by your
consent settings
Early Coronary Artery Disease in a Female Patient with Discoid Lupus Erythematosus and Hashimoto’s Thyroiditis
(Scientific Foundation SPIROSKI, 2023-08-15)
Dimitrovska, Biljana
;
Jovchevska, Simona
;
Bede, I.
;
Vraynko, Elif
;
BACKGROUND: Atherosclerosis is a chronic inflammatory condition involving the endothelium of the blood vessels, predominant the coronary arteries. Main risk factors are dyslipidemia, hypertension, diabetes, smoking, obesity, and lack of physical activity. Patients with autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis etc., have a twofold increased risk of developing CAD at younger age, compared with the general population. CASE REPORT: A 41-year-old female patient, with history of smoking and dyslipidemia, was admitted to our hospital with acute inferoposterior myocardial infarction. Initially, coronary reperfusion therapy per protocol was administrated and primary percutaneous coronary intervention (PCI) was performed. Multivessel CAD was found, and two stents were implanted on obtuse marginal and circumflex artery. Transthoracic echocardiography (TTE) revealed left ventricle systolic and diastolic dysfunction with segmental hypokinesis. Additionally, the patient was first diagnosed with DLE at the age of 15, but the disease was uncontrolled in the last 7 years. She also has hypothyroidism, regularly treated with hormone replacement therapy. The patient was discharged with medicamentous therapy including dual antiplatelet agents, statin, beta-blocker, angiotensin-receptor blocker, potassium sparing diuretic and proton pump inhibitor. One month later, recoronarography was performed with stenting of left anterior descending artery. TTE showed improvement of the left ventricle systolic function with preserved ejection fraction. The blood test showed elevated levels of antithyroid antibodies. A rheumatologist was consulted, who recommended therapy with hydroxychloroquine and regular follow-ups. CONCLUSION: In younger patients with chronic inflammatory diseases, inflammatory mediators play a significant role in the development of the atherosclerotic plaques, regardless of co-existing risk factors. Therefore, an early cardiovascular assessment is required in these patients for preventing severe or life-threatening cardiovascular events.
Some of the metrics are blocked by your
consent settings
Bilateral retrograde radial approach in stenting of occluded subclavian artery
(Oxford University Press (OUP), 2013-08-02)
Petkoska, D.
;
;
Jovkovski, A.
;
Some of the metrics are blocked by your
consent settings
Transradial carotid artery stenting in high risk patients
(Oxford University Press (OUP), 2016-08-29)
Petkoska, Danica
;
;
Antov, Slobodan
;
Vasilev, Ivan
;
Some of the metrics are blocked by your
consent settings
Sex differences in transradial access failure in ST segment elevation myocardial infarction
(Wiley, 2024-11)
;
Jovkovski, Aleksandar
;
Vasilev, Ivan
;
Taravari, Hajber
;
Kitanoski, Darko
Background Transradial access (TRA) is now the default access site for PPCI, but technically is a more challenging approach mostly due to anatomic challenges connected to the RA. Aims To assess the differences according to sex in radial artery (RA) access site characteristics during primary percutaneous coronary intervention (PPCI) for ST segment elevation myocardial infarction (STEMI). Material and Methods All 5092 consecutive STEMI patients from our center in the period from March 2011 until December 2017 were examined. The right proximal radial was the “intention-to-treat” access in all patients. Preprocedural RA angiography was performed in all patients. Clinical and procedure characteristics, type of radial anatomy variants, need to use another arterial access sites (the primary endpoint for this study), and procedure time were analyzed by sex. Using logistic regression, we selected predictors of radial crossover. Access site bleeding complications and vascular complications were also recorded. Results The STEMI population in this period included 1326 females and 3766 male patients. Females were older (65 ± 11 years) than males (59 ± 11 years, p < 0.0001). Among standard risk factors, hypertension and diabetes mellitus were more common in women and smoking less common. RA anomalies were more frequent in the females (8.8% vs. 6.5%, p < 0.0001), with complex RA loop and tortuous RA twice as frequent in women. Failure of TRA access as the initially chosen site occurred in 4.6% (61) of females versus 2.5% (97) of male STEMI patients (p = 0.0003). The most common subsequent access site was right ulnar access in both groups (57 and 61% respectively). Access site bleeding complications were more common in women 4.4% versus 3.2%, mirrored in hematomas with EASY score III to V. Clinical RA spasm (RAS) was significantly more frequent in females (5.7% vs. 2.2%, p < 0.0001). Multiple regression analysis identified 5 independent predictors for TRA access crossover: previous TRA, anomalous RA, RAS, along with female sex and diabetes. Conclusion Female sex is a significant predictor of more complex TRA in STEMI. Understanding sex differences and predictors for TRA crossover will strengthen the use of different procedural modalities that can help in preserving a successful wrist access in female STEMI patients.

Zafirovska Taleska, Biljana

Filters

Settings

Sort By

Results per page